Evidence map›Paper›PMID 27485192›Full record

ArticleCancer medicine2016

Abdomen/pelvis computed tomography in staging of pediatric Hodgkin Lymphoma: is it always necessary?

Piero Farruggia, Giuseppe Puccio, Alessandra Sala, Alessandra Todesco, Monica Terenziani, Rosamaria Mura, Salvatore D'Amico, Tommaso Casini, Clara Mosa, Marta Pillon and 12 more

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 16 institutions in 2 countries.

Piero FarruggiaPediatric Hematology and Oncology Unit, Oncology Department, A.R.N.A.S. Ospedali Civico, Di Cristina e Benfratelli, Palermo, Italy. piero.farruggia@arnascivico.it, pfarruggia@libero.it.
Giuseppe PuccioDepartment of Sciences for Health Promotion and Mother and Child Care, University of Palermo, Palermo, Italy.
Alessandra SalaClinica Pediatrica, Universita' Milano - Bicocca, A.O. San Gerardo, Fondazione Monza e Brianza per il bambino e la sua mamma (MBBM), Monza, Italy.
Alessandra TodescoDipartimento di Oncoematologia Pediatrica, Università di Padova, Padova, Italy.
Monica TerenzianiPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Rosamaria MuraPediatric Hematology-Oncology, Ospedale Pediatrico Microcitemico, Cagliari, Italy.
Salvatore D'AmicoOncologia Pediatrica, Clinica Pediatrica, Catania, Italy.
Tommaso CasiniDipartimento di Oncoematologia Pediatrica, A.O.U Meyer, Firenze, Italy.
Clara MosaPediatric Hematology and Oncology Unit, Oncology Department, A.R.N.A.S. Ospedali Civico, Di Cristina e Benfratelli, Palermo, Italy.
Marta PillonDipartimento di Oncoematologia Pediatrica, Università di Padova, Padova, Italy.
Maria Paola BoaroDipartimento di Oncoematologia Pediatrica, Università di Padova, Padova, Italy.
Gaetano BottiglieroDipartimento di Pediatria II Ateneo di Napoli, Servizio di Oncologia Pediatrica, Napoli, Italy.
Roberta BurnelliOncoematologia Pediatrica, Azienda Ospedaliera Universitaria, Ospedale Sant'Anna, Ferrara, Italy.
Caterina ConsarinoPediatric Hemato-oncology Unit, Dipartimento di Onco-Ematologia, Catanzaro Hospital, Catanzaro, Italy.
Fausto FedeliDepartment of Pediatrics, Niguarda Ca' Granda Hospital, Milano, Italy.
Maurizio MascarinS.S. Radioterapia Pediatrica e Area Giovani, IRCCS, Centro di Riferimento Oncologico Aviano, Pordenone, Italy.
Katia PerruccioOncoematologia Pediatrica, Azienda Ospedaliera-Universitaria di Perugia, Perugia, Italy.
Elisabetta SchiavelloPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Angela TrizzinoPediatric Hematology and Oncology Unit, Oncology Department, A.R.N.A.S. Ospedali Civico, Di Cristina e Benfratelli, Palermo, Italy.
Umberto FicolaDipartimento Oncologico La Maddalena, Medicina Nucleare, Palermo, Italy.
Alberto GaraventaDipartimento di Ematologia e Oncologia Pediatrica Istituto G. Gaslini, Genova, Italy.
Mario RosselloRadiology Unit, Radiology Department, A.R.N.A.S. Ospedali Civico, Di Cristina e Benfratelli, Palermo, Italy.
Azienda di Rilievo Nazionale ed Alta Specializzazione · ITUniversity of Padua · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITAccademia di Belle Arti di Catanzaro · ITAzienda Ospedaliera di Perugia · ITAzienda Ospedaliera San Gerardo · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITIstituto Giannina Gaslini · ITIstituto Nazionale di Fisica Nucleare, Sezione di Napoli · ITLa Maddalena · ITMeyer Children's Hospital · ITOspedale Garibaldi · ITOspedale Microcitemico · ITOspedale Sant'Anna · ITUniversity of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of the study was to determine if abdomen/pelvis computed tomography (CT) can be safety omitted in the initial staging of a subgroup of children affected by Hodgkin Lymphoma (HL). Every participating center of A.I.E.O.P (Associazione Italiana di Ematologia ed Oncologia Pediatrica) sent local staging reports of 18F-fluorodeoxyglucose positron emission tomography (PET) and abdominal ultrasound (US) along with digital images of staging abdomen/pelvis CT to the investigation center where the CT scans were evaluated by an experienced pediatric radiologist. The local radiologist who performed the US was unaware of local CT and PET reports (both carried out after US), and the reviewer radiologist examining the CT images was unaware of local US, PET and CT reports. A new abdominal staging of 123 patients performed on the basis of local US report, local PET report, and centralized CT report was then compared to a simpler staging based on local US and PET. No additional lesion was discovered by CT in patients with abdomen/pelvis negativity in both US and PET or isolated spleen positivity in US (or US and PET), and so it seems that in the initial staging, abdomen/pelvis CT can be safety omitted in about 1/2 to 2/3 of children diagnosed with HL.

Indexed as

Tomography, X-Ray ComputedAbdomenFemaleHodgkin DiseaseHumansLymph NodesMaleMultimodal ImagingNeoplasm StagingPelvisPositron-Emission TomographyPositron Emission Tomography Computed TomographySensitivity and SpecificityChildhoodHodgkin LymphomaPET

Identifiers

PMID27485192
PMCPMC5055149
OpenAlexW2497478361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.